BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15146583)

  • 21. Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure.
    Ray L; Mathieu M; Jespers P; Hadad I; Mahmoudabady M; Pensis A; Motte S; Peters IR; Naeije R; McEntee K
    Exp Physiol; 2008 Mar; 93(3):434-42. PubMed ID: 17993509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
    Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
    Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin transporter and serotonin receptors.
    Adnot S; Houssaini A; Abid S; Marcos E; Amsellem V
    Handb Exp Pharmacol; 2013; 218():365-80. PubMed ID: 24092348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary pulmonary hypertension in childhood: familial aspects].
    Squarcia U; Carano N; Agnetti A; Haitink O; Giovannelli G
    Pediatr Med Chir; 1981; 3(6):467-72. PubMed ID: 7343943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic variation in the serotonin transporter (5HTT) gene contributes to idiopathic pulmonary hypertension in children.
    Vachharajani A; Saunders S
    Biochem Biophys Res Commun; 2005 Aug; 334(2):376-9. PubMed ID: 16009349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetics of pulmonary arterial hypertension: current and future implications.
    Elliott CG
    Semin Respir Crit Care Med; 2005 Aug; 26(4):365-71. PubMed ID: 16121312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
    Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
    J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the genetic and molecular basis of primary pulmonary hypertension.
    Trembath RC; Harrison R
    Pediatr Res; 2003 Jun; 53(6):883-8. PubMed ID: 12621102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathobiology of pulmonary hypertension. Endothelium.
    Tuder RM; Cool CD; Yeager M; Taraseviciene-Stewart L; Bull TM; Voelkel NF
    Clin Chest Med; 2001 Sep; 22(3):405-18. PubMed ID: 11590837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide gene alterations in patients with idiopathic pulmonary arterial hypertension.
    Haberl I; Frei K; Ramsebner R; Doberer D; Petkov V; Albinni S; Lang I; Lucas T; Mosgoeller W
    Eur J Hum Genet; 2007 Jan; 15(1):18-22. PubMed ID: 17003842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of pulmonary hypertension.
    Yildiz P
    Clin Chim Acta; 2009 May; 403(1-2):9-16. PubMed ID: 19361468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous endothelial progenitor cells transplantation for the therapy of primary pulmonary hypertension.
    Zeng C; Wang X; Hu X; Chen J; Wang L
    Med Hypotheses; 2007; 68(6):1292-5. PubMed ID: 17140742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats.
    Ono M; Sawa Y; Mizuno S; Fukushima N; Ichikawa H; Bessho K; Nakamura T; Matsuda H
    Circulation; 2004 Nov; 110(18):2896-902. PubMed ID: 15505094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary pulmonary hypertension.
    Oliaro E; Grosso Marra W; Orzan F
    Minerva Cardioangiol; 2000 Nov; 48(11):361-78. PubMed ID: 11214428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The enigma of pulmonary hypertension of undetermined origin].
    Roncoroni AJ
    Medicina (B Aires); 2002; 62(4):349-57. PubMed ID: 12325496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.
    Lee SD; Shroyer KR; Markham NE; Cool CD; Voelkel NF; Tuder RM
    J Clin Invest; 1998 Mar; 101(5):927-34. PubMed ID: 9486960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Definition, concept and pathophysiology of pulmonary hypertension].
    Kunieda T
    Nihon Rinsho; 2001 Jun; 59(6):1037-46. PubMed ID: 11411110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary hypertension of the lesser circulation].
    Kriuchkova TS; Eremeeva AS
    Arkh Patol; 1976; 38(5):84-9. PubMed ID: 799495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serotonin and pulmonary arterial hypertension].
    Eddahibi S; Adnot S
    Rev Mal Respir; 2006 Apr; 23 Suppl 2():4S45-4S51. PubMed ID: 16733400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].
    Duong-Quy S; Rivière S; Bei Y; Duong-Ngo C; Le-Dong NN; Hua-Huy T; Dinh-Xuan AT
    Rev Mal Respir; 2012 Oct; 29(8):956-70. PubMed ID: 23101638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.